get ready shorts.
are you a Farmer? they have plenty of cash... thats the last thing to happen...
if you want to say something negative.. say something make sense.
you keep saying the same thing when they were at $6, $7 and $8... keep doing what you doing and I am sure you going to be a big winner.... please tell me what else you shorting... I want to buy them.
NASDAQ:ARIA)‘s stock had its “outperform” rating reiterated by equities research analysts at Cowen and Company in a research note issued to investors on Thursday. They currently have a $10.00 price target on the pharmaceutical company’s stock. Cowen and Company’s target price would suggest a potential upside of 27.39% from the stock’s previous close.
they were talking about Roche cancer drug that getting approve by the end of this year and they mentioned Aria too that my have a cancer drug to be approve soon.
He can buy them next month or 3 months from now... but he can't buy them at this price.. ASCO and Japan news will drive the price over $10.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) CEO Paris Panayiotopoulos purchased 26,990 shares of the firm’s stock in a transaction on Thursday, May 12th. The shares were purchased at an average cost of $7.41 per share, with a total value of $199,995.90. Following the completion of the transaction, the chief executive officer now owns 61,099 shares of the company’s stock, valued at approximately $452,743.59. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
buy.. buy... buy and miki said ASCO abd Japan news on the way...